Publications
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis2012 | First Faculty of Medicine
- Biologic treatment of rheumatic diseases in children2012 | First Faculty of Medicine
- Anakinra2011 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Development and Initial Validation of Composite Parent- and Child-Centered Disease Assessment Indices for Juvenile Idiopathic Arthritis2011 | First Faculty of Medicine
- 677TT Genotype is associated with elevated risk of methotrexate (MTX) toxicity in juvenile idiopathic arthritis: treatment outcome, erythrocyte concentrations of MTX and folates, and MTHFR polymorphisms2010 | Faculty of Physical Education and Sport, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- 677TT Genotype Is Associated with Elevated Risk of Methotrexate (MTX) Toxicity in Juvenile Idiopathic Arthritis: Treatment Outcome, Erythrocyte Concentrations of MTX and Folates, and MTHFR Polymorphisms2010 | First Faculty of Medicine
- Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in Remission A Randomized Clinical Trial2010 | First Faculty of Medicine
- Methotrexate bioavailability after oral and subcutaneous administration in children with juvenile idiopathic arthritis2009 | First Faculty of Medicine
- An improved high-performance liquid chromatography method for quantification of methotrexate polyglutamates in red blood cells of children with juvenile idiopathic arthritis2009 | First Faculty of Medicine
- Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study2007 | First Faculty of Medicine
Loading network view...